Market Place
Sourcing Support
All News #Library
Others
OBI Pharma, TegMine Partner On ADCs Using GlycOBI & TegMiner Tech
06 Jun 2025 //
GLOBENEWSWIRE
OBI Pharma Wins ‘Most Promising ADC Clinical Candidate’ In Taiwan
12 Mar 2025 //
GLOBENEWSWIRE
OBI Pharma Enters Japan Collab with GlyTech for Glycan Production
23 Dec 2024 //
GLOBENEWSWIRE
OBI Pharma Appoints Heidi Wang, Ph.D. as Chief Executive Officer
02 Jun 2023 //
GLOBENEWSWIRE
OBI Pharma Announces Discontinuation of PI/II Study of its Antibody- OBI 888
05 Jul 2022 //
GLOBENEWSWIRE
OBI Pharma Announces Poster Presentations at the 2022 ASCO
17 May 2022 //
GLOBENEWSWIRE
OBI Pharma Announces Poster Presentations at AACR 2022
07 Apr 2022 //
PRNEWSWIRE
Biosion Licenses BSI04702, to OBI for WW Development & Commercialization Rights
11 Dec 2021 //
PRNEWSWIRE
OBI Pharma Announces First Patient Enrolled on SWOG Cancer Research OBI-3424
26 Apr 2021 //
PRNEWSWIRE
OBI Pharma Announces First Patient Enrolled on SWOG Network`s OBI-3424
26 Apr 2021 //
PRNEWSWIRE
OBI Announces Poster Presentations at AACR 2021 Annual Meeting for OBI-3424
06 Apr 2021 //
PRNEWSWIRE
OBI Pharma Announces Poster at 2020 ASCO Adagloxad Simolenin, OBI-999,OBI-3424
20 May 2020 //
PRNEWSWIRE
OBI Pharma Updates on Clinical Trial Activities During COVID-19 Pandemic
08 Apr 2020 //
PRNEWSWIRE
OBI Announces Poster Presentations at AACR 2021 Annual Meeting for OBI-3424
05 Apr 2020 //
PRNEWSWIRE
OBI Pharma Granted FDA Orphan Drug Designation for Treatment of Gastric Cancer
21 Jan 2020 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.